This is a U.S. news story, published by Yahoo, that relates primarily to Moderna news.
For more U.S. news, you can click here:
more U.S. newsFor more Moderna news, you can click here:
more Moderna newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
bird flu vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest vaccine maker news, vaccine production news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Covid vaccineReuters
•Health
Health
79% Informative
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine.
The review is part of a push to examine spending on messenger RNA -based vaccines.
Shares of vaccine maker fell 5.5% in after-market trading.
VR Score
90
Informative language
97
Neutral language
42
Article tone
formal
Language
English
Language complexity
55
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links
